BioSpace

6 potential blockbusters that could pave China’s path to 2030 ambitions

In its latest five-year plan, China has set its sights on developing five drugs that could each rake in more than $1 billion globally by 2030. Experts say it's well on its way, with two medications having already met that bar.

By BioSpace

1 min read
6 potential blockbusters that could pave China’s path to 2030 ambitions
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights